Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

HCW Biologics (HCWB) Return on Capital Employed (2021 - 2025)

HCW Biologics (HCWB) has disclosed Return on Capital Employed for 5 consecutive years, with 37.39% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Capital Employed fell 4837.0% year-over-year to 37.39%, compared with a TTM value of 37.39% through Sep 2025, down 4837.0%, and an annual FY2024 reading of 116.17%, up 11706.0% over the prior year.
  • Return on Capital Employed was 37.39% for Q3 2025 at HCW Biologics, down from 16.31% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 23.92% in Q4 2024 and bottomed at 37.39% in Q3 2025.
  • Average Return on Capital Employed over 5 years is 3.15%, with a median of 0.46% recorded in 2023.
  • The sharpest move saw Return on Capital Employed skyrocketed 2502bps in 2024, then tumbled -4837bps in 2025.
  • Year by year, Return on Capital Employed stood at 0.25% in 2021, then fell by -29bps to 0.33% in 2022, then crashed by -237bps to 1.1% in 2023, then soared by 2269bps to 23.92% in 2024, then tumbled by -256bps to 37.39% in 2025.
  • Business Quant data shows Return on Capital Employed for HCWB at 37.39% in Q3 2025, 16.31% in Q2 2025, and 21.41% in Q1 2025.